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TABLE 2. Viability of encapsulated LEW spleen cells incubated with 
ACI anti-LEW antiserum 
';' viability" 
Time Encapsulated Free 
Ab + C- Ab NS' + C' NS Ab + C' Ab NS+ C' NS 
0 85 85 92 92 
16h 8 79 81 83 0 89 88 94 
" ~ean of three determinations; O.I-ml microcapsules (4 x 10' cellsl 
ml) or 4 x 10" free LEW splenocytes were incubated in 0.9 ml of M199 
or supplemented with Ab or NS. 
h NS. normal ACI serum: C'. rabbit complement. 
host sensitization. Even with intact microcapsular membrane 
the intra capsular splenocytes were still destroyed in vitro by 
their respective antiserum. thus indicating that the membrane 
was permeable to y-globulins. 
In vivo implantation of empty microcapsules i.p. also induced 
an inflammatory response in the host animal. Therefore. in 
order to realize the theoretical advantage of microencapsulation 
over that of the hollow fiber unit and micro pore chamber. 
improvements of the encapsulation process with biocompatible 
polymers of high tensile strength and durability and with a 
better defined molecular weight cut-off will have to be achieved. 
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POSITIVE. WARM T CELL CROSSMATCH IN CARDIAC TRANSPLANTATION: WITH TRANSIENT VASCC'LITIS 
AND WITHOUT HYPERACUTE REJECTION 
Testing for cytotoxic antibodies in recipient serum. against 
donor lymphocytes. is perhaps the most important test done 
prior to allotransplantation. With the possible exception of liver 
transplants. a positive T cell crossmatch at 37 C is generally 
considered to be an absolute contraindication for organ trans-
plantation (I, 2). The status of other types of positive cross-
matches remains to be clarified (3.4). Allotransplantation done 
in the presence of a positive, warm T cell crossmatch does not 
always result in immediate graft loss. although hyperacute 
rejection or accelerated rejection is frequent. 
Both hyperacute rejection and graft survival have been de-
scribed in cardiac transplants done in the presence of a. positive 
crossmatch (5. 6). We observed an intennediate outcome with 
early graft injury without immediate loss of the organ in a 
patient who received a cardiac transplant from a crossmatch-
positive donor. The relevant clinical data are presented below: 
MB. a 48-year-old white woman, presented with severe con-
gestive heart failure requiring vasopressors immediately follow-
ing cardiac catheterization. Coronary arteries were normal and 
a diagnosis of cardiomyopathy with biventricular dysfunction 
was made. Cardiac transplantation was done on the 5th hospital 
day (recipient HLA type A2,A24 (9),B7,B27,DR2; donor HLA 
type A3,A26(10),BI5,B22,DR2,DR7). 
The recipient suffered a cardiac arrest within 2 hr of trans-
plantation, but she was successfully resuscitated. She was 
treated with cyclosporin A and prednisolone. Cyclosporin A 
was given orally at a dose of 17.5 mg/kg/day for 19 days when 
a rise in bilirubin was observed and the dose reduced to 6.5 mg/ 
kg/day. She received 1 g of methylprednisolone at surgery and 
1 g of cortisol i.v., every 4 hr for 24 hr. On the 2nd postoperative 
day, she received 200 mg of prednisone orally. The prednisone 
dose was reduced by 20 mg/day until 30 mg/day was reached. 
The donor heart was obtained from a distant city and the 
crossmatch between donor lymph node cells and the recipient 
serum was completed after transplantation. The crossmatch 
was carried out by the two-color fluorescence method at 4 and 
:37 C (7; Rabin et al .• unpublished data). The crossmatch vas 
positive at both temperatures against both T and B lympho-
cytes at a serum dilution of 1:4. Following a single platelet 
absorption of the patient's serum. the crossmatch was negative. 
The patient's pretransplant serum was tested for the presence 
oflymphocytotoxic antibodies using a 26-member random panel 
by the trypan blue dye exclusion method. The patient's serum 
was cytotoxic to T and B lymphocytes from 50% of the panel 
members. 
Three transvenous endomyocardial biopsies were done each 
month during the 2-month post-transplant period. The regults 
of biopsy findings are outlined in Figure 1. The biopsy taken 1 
week after transplantation showed focal lymphocytic and neu-
trophilic infIltration with edema. The changes were felt to be 
consistent with mild acute rejection. The biopsy taken 22 days 
after transplantation exhibited edema with mild neutrophilic 
infiltration and focal myocytolysis without any appreciable 
lymphocytic infiltration. The biopsy taken 53 days after trans-
plantation showed moderate, acute cellular rejection with nod-
ular aggregates of lymphocytes, focal myocytolysis. and endo-
cardial fibrosis. 
Four of the biopsies were examined by direct immunofluo-
rescence for IgG, IgM, IgA, C3, C4, Clq, properdin, and fibrin-
ogen. Vascular deposition of IgG and C3 were present in the 
biopsy taken 1 week after transplantation (Fig. 2). IgG, IgM, 
C3, C4, and fibrinogen deposits were seen in the vessel walls in. 
the biopsy taken 22 days postoperatively. The succeeding biop-
sies were negative by direct immunofluorescence (Fig. 1). 
Postoperative serum specimens were examined for the pres-
ence of antibodies cytotoxic to donor cells by the same tech": 
nique used for the original crossmatch. The serum taken 9 days 
post-transplantation gave a positive, warm T cell crossmatch 
with a titer of 32, a specimen taken 24 days post-transplantation 
was positive only when tested undiluted. The serum specimens 
taken 27 and 53 days post-transplantation were negative for· 
donor lymphocyte-specific cytotoxic antibodies (Fig. 1). 
., 
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FIGURE 1. Biopsy findings: The type 
test done is indicated on the vertical 
. axis and the post-transplant days on 
which the tests were conducted are in-
dicated on the horizontal axis. Necrosis 
myocardial fibers, edema, neutrophilic 
and lymphocytic infiltrate 
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assessed from biopsy specimens 
processed for light microscopy. Direct 
immunofluorescence was done on sepa-
rate specimens processed as frozen sec-
. tions. Crossmatch titers indicate the se-
rum dilution at which more than 80% of 
the donor lymphocytes were killed. Cel-
lular reactivity and transformation per-
tain to the in vitro tests with saline ex-
tract of donor heart tissue. + • POSITIVE OR PRESENT 
- • NEGATIVE OR ABSENT 
The patient's lymphocytes were tested (62 days post-trans-
plantation) for their reactivity to donor heart tissue. The stim-
ulation index. on incubating the patient's lymphocytes with 
saline extract of donor heart tissue, was 5.7 whereas the index 
in response to third-party liver extract was 2.4. The patient's 
lymphoc~Dtes were also tested for their ability to produce leu-
koC':,·te migration inhibition factor in an indirect assay using 
saline extract of donor heart and third-party liver extract. The 
migration inhibition index with the donor heart extract was 
0.64. The patient's lymphocytes, on exposure to third-party 
liver extract. and lymphocytes from a normal donor on exposure 
to donor heart and third-party liver extract, failed to produce 
leukocyte migration inhibition factor. 
---------- The patient's EKGs demonstrated reduction in voltage in the 
earlv post-transplant period. However, the output stabilized by 
the 30th post-transplant day. The patient was discharged in a 
stable, though not a satisfactory, condition 8 weeks post-trans-
plantation. She expired 2 weeks later with a 7-cm mediastinal 
abscess and bilateral pneumonia. Histologically, the ventricular 
myocardium showed edema and mild focal individual cell ne-
crosis. The vascular endothelial cells were prominent, but no 
evidence of accelerated atherosclerosis was present. 
The patient's course, especially the study of endomyocardial 
FIGURE 2. The endomyocardial biopsy 
was stained with fluorescein-conjugated 
antihuman C3 antibod~DK The deposition 
of C3 in small vessels is evident. IgG, 
Ig-M, C4, and fibrinogen deposition were 
seen in similar distribu tion. 
biopsies (Fig. 1), points to a transient vascular injury initiated 
by the deposition of alloantibodies in addition to acute cellular 
rejection episodes. The outcome, however, was not hyperacute 
rejection as is the usual case with preformed antibodies. Al-
though the treatment may have altered the appearance of the 
lesions, the histological findings during the period when direct 
immunofluorescence was positive were not entirely consistent 
with cell-mediated acute rejection, especially around postoper-
ative days 22 to 24. The early picture can thus be described as 
an alloantibody-mediated vasculitis with mild acute rejection, 
leading to transient graft injury with recovery. We have no 
explanation for the nonprogressive nature of the vasculitis or 
the disappearance of the preformed antidonor antibodies in the 
patient's serum. Hypogammaglobulinemia did not occur during 
the course of observation. Although we were unable to serially 
test the cellular response to donor tissue, the single test (mito-
genic response and leukocyte migration inhibition factor pro-
duction) was positive at a time when biopsy findings indicated 
acute cellular rejection. 
Despite general agreement that allotransplants should not be 
done when a warm T cell crossmatch is positive, there may not 
be enough time to wait for the results of the crossmatch because 
of limited tolerance of the organ to ischemia. The indication of 
--------~-~---
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the presence of antiallotypic antibodies in the patient's serum 
can be obtained by testing the serum against a panel of lym-
phocytes. The use of a panel of lymphocytes frozen and stored 
in Terasaki tissue typing trays was found to expedite such 
screening (8). It is being suggested that quick screening should 
be carried out for all prospective recipients to estimate the 
probability of a positive crossmatch against a random donor. 
By using lymphocytes frozen in Terasaki trays, a quick screen-
ing could be carried out for all patients within a matter of about 
5 hr. A patient reacting with 50% of the panel members has 
roughly a 50% chance of having a positive crossmatch with a 
random donor. It may, at times, not be possible to wait for the 
crossmatch results before transplantation; under su'ch circum-
stances, knowing the probability of a positive crossmatch 
against a random donor may facilitate the decision for under-
taking or not undertaking a transplant. We are in agreement 
with the recommendation of Weil et al. (5) that cardiac trans-
plantation should not be done in the presence of a positive, 
warm T cell crossmatch unless the patient is not likely to 
survive long enough to wait for another organ. 
In summary, we have described a patient who had cytotoxic 
antibodies to 50% of the members of a random panel and had 
a positive, warm T cell cross match with the donor lymphocytes. 
The cardiac transplant suffered transient vasculitis, but did not 
undergo hyperacute rejection. Evidence for humoral rejection. 
i.e., positive direct immunofluorescence and positive cross-
matches. waned despite initial positivity. Humoral and cellular 
rejection were present simultaneously in the initial period, but 
were discordant after the initial 2 weeks. It is suggested that 
quick screening for lymphocytotoxic antibodies be carried out 
using lymphocytes frozen in Terasaki typing trays to determine 
the likelihood of a positive crossmatch. Whenever possible, 
transplantation in the face of a positive crossmatch should be 
avoided. 
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VALUE OF A PHYSIOLOGICAL LIVER TRANSPLANT MODEL IN RATS 
INDUCTION OF SPECIFIC GRAFT TOLERANCE IN A FULLY ALLOGENEIC STRAIN COMBINATION' 
With the one known exception of spontaneous graft tolerance, 
DA -. PVG (1,2), fully allogeneic rat liver transplantation 
(RL T) still shows very poor results, whereas in more than one 
semiallogeneic combination specific transplantation tolerance 
has been achieved (3,4). RLT, whether performed.in an aux-
iliary heterotopic model (4) or in variously modified orthotopic 
models (1,5-7), has, so far, not yet been immunologically 
analyzed after reanastomosis of the hepatic artery. Major com-
plications after RLT, such as biliary peritonitis and bile duct 
necrosis, may be attributable to the lack of arterial blood 
supply. 
Improving the modified orthotopic technique described by 
Lee et ai. (8), by reanastomosing the hepatic artery, syngeneic 
LEW and fully allogeneic BN livers were grafted into LEW 
recipients. In comparison of the results of transplantations 
performed with reanastomosis of the hepatic artery (REART) 
to those performed under nonrearterialized (Non-REART) con-
'This work was supported by the Deutsche Forschungsgemeinschaft 
in SFB 111, B 9. 
ditions, we will show: (1) dramatic increase of isograft survival 
using the optimized technique, (2) improvement of graft mor-
phology, (3) elimination of unspecific cell-mediated in vitro 
reactivity, and (4) specific transplantation tolerance in the fully 
allogeneic BN -+ LEW combination, 
By using the inbred rat strains LEW (RT11) and BN (RT1 n), 
the following four combinations were studied: LEW -+ LEW 
Non-REART, n = 22, REART, n = 17 and BN -+ LEW Non-
REART, n = 8, REART, n = 12. RL T (Non-REART) was 
perfonned with the modified orthotopic Lee technique (8) 
using a polyethylene cuff for bile duct anastomosis. In REART 
rats in addition to suprahepatic inferior vena cava anastomosis, 
portal vein anastomosis and anastomosis of the infrahepatic 
inferior vena cava, the aorta of the donor, bearing the celiac 
axis and the hepatic artery, was anastomosed in an end to side 
fashion to the recipient's infrarenal aorta. Mean operation time 
for Non-REART rats was 45 min, for REART rats 70 min. 
Survival rates were evaluated and morphological studies of the 
liver (open liver biopsies were taken at day 10 and then in 4-
week intervals) were performed in every surviving animal. Cell-
